Get App

UnitedHealth CEO says no copay for insulin, other critical drugs from 2023

The news comes amid heightened public scrutiny over soaring prices of the life-saving drug, with the U.S. House of Representatives in March passing a bill that caps monthly out-of-pocket insulin costs at $35 for those with health insurance.
  • Updated On Jul 16, 2022 at 06:20 AM IST
Read by: 100 Industry Professionals
Reader Image Read by 100 Industry Professionals
UnitedHealth Inc Chief Executive Officer Andrew Witty said on Friday that beginning next year there would be no copay or out-of-pocket costs for several critical medicines, including insulin, for fully insured members.

The news comes amid heightened public scrutiny over soaring prices of the life-saving drug, with the U.S. House of Representatives in March passing a bill that caps monthly out-of-pocket insulin costs at $35 for those with health insurance.

Other medicines in the list include epinephrine for severe allergic reactions and albuterol for acute asthma attacks, Witty said.
  • Published On Jul 16, 2022 at 06:17 AM IST
Be the first one to comment.
Comment Now

COMMENTS

Comment Now Read Comment (1)

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles
Scan to download App